SCHEMBL1090942

SCHEMBL1090942

c1ccc2c(c1)CCN(c1nc(NCCCn3ccnc3)nc3ccccc13)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.51
ALDH1A1 P00352 1/20 0.50
GSK3A P49840 1/20 0.50
GSK3B P49841 1/20 0.50
GBA1 P04062 1/20 0.48
SOD1 P00441 3/20 0.47
NAMPT P43490 4/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
QPCT Q16769 1/20 0.45
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
TLR9 Q9NR96 1/20 0.41
TLR7 Q9NYK1 1/20 0.41
MRGPRX1 Q96LB2 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089224 0.86 SCN9A (0.55) SCN9AALDH1A1GSK3AGSK3BSOD1
SCHEMBL1089693 0.85 SCN9A (0.55) SCN9AALDH1A1GSK3AGSK3BSOD1
SCHEMBL1090384 0.85 SCN9A (0.55) SCN9AALDH1A1GSK3AGSK3BSOD1
SCHEMBL1089534 0.85 SCN9A (0.55) SCN9AALDH1A1GSK3AGSK3BSOD1
SCHEMBL1091393 0.83 HRH3 (0.54) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1091105 0.81 KDM4E (0.57) ALDH1A1GBA1SMN1; SMN2KDM4ETSHR
SCHEMBL2953910 0.80 CACNA2D1 (0.47) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2955070 0.79 KDM1A (0.49) SCN9AALDH1A1GBA1GRIN2DGRIN3B
SCHEMBL1089853 0.79 MRGPRX1 (0.51) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1090653 0.79 MRGPRX1 (0.61) GBA1SMN1; SMN2GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 SCN9A 1243/4885ALDH1A1 916/4885GSK3A 855/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 SCN9A 1243/4885ALDH1A1 916/4885GSK3A 855/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 SCN9A 1243/4885ALDH1A1 916/4885GSK3A 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.